Results 21 to 30 of about 40,857 (208)

Mothers' Knowledge and Practices Regarding Care of their Children with Respiratory Syncytial Virus [PDF]

open access: yesTanta Scientific Nursing Journal, 2023
Background: Respiratory syncytial virus is the chief cause of lower respiratory tractinfections in children which causes mild to severe symptoms. Aim: To assess mothers'knowledge and practices regarding care of their children with Respiratory Syncytial ...
Adel Abdelwahab   +2 more
doaj   +1 more source

The epidemiology and severity of respiratory viral infections in a tropical country: Ecuador, 2009–2016

open access: yesJournal of Infection and Public Health, 2019
Background: Respiratory viral infections (RVI) are a leading cause of mortality worldwide. We compared the epidemiology and severity of RVI in Ecuador during 2009–2016. Methods: Respiratory specimens collected within the national surveillance system were
Saverio Caini   +11 more
doaj   +1 more source

Epidemiological characteristics and phylogenic analysis of human respiratory syncytial virus in patients with respiratory infections during 2011–2016 in southern China

open access: yesInternational Journal of Infectious Diseases, 2020
Background: Human respiratory syncytial virus (RSV) is one of the most important pathogens that cause acute respiratory infections in children and immunocompromised adults.
Hong-jiao Luo   +12 more
doaj   +1 more source

Safety and immunogenicity of an intranasal sendai virus-based vaccine for human parainfluenza virus type I and respiratory syncytial virus (SeVRSV) in adults

open access: yesHuman Vaccines & Immunotherapeutics, 2021
SeVRSV is a replication-competent Sendai virus (SeV)-based vaccine carrying the respiratory syncytial virus (RSV) fusion protein (F) gene. Unmanipulated, non-recombinant SeV is a murine parainfluenza virus type 1 (PIV-1) and serves as a Jennerian vaccine
Felicia Scaggs Huang   +16 more
doaj   +1 more source

Off-season RSV epidemics in Australia after easing of COVID-19 restrictions

open access: yesNature Communications, 2022
Non-pharmaceutical interventions for COVID-19 also reduced incidence of respiratory pathogens such as respiratory syncytial virus (RSV). Here, the authors report the resurgence of RSV in Australia following lifting of some of the restrictions and ...
John-Sebastian Eden   +25 more
doaj   +1 more source

Genomic Sequencing Surveillance to Identify Respiratory Syncytial Virus Mutations, Arizona, USA

open access: yesEmerging Infectious Diseases, 2023
We conducted surveillance of respiratory syncytial virus (RSV) genomic sequences for 100 RSV-A and 27 RSV-B specimens collected during November 2022–April 2023 in Arizona, USA.
LaRinda A. Holland   +9 more
doaj   +1 more source

Respiratory syncytial virus and Streptococcus pneumoniae Co-infection in an elderly individual within a familial cluster

open access: yesJournal of Medical Sciences, 2023
Respiratory syncytial virus (RSV) is a common pathogen that causes respiratory tract infection and has been found to co-infect with other bacteria. Although the virus can cause morbidity and mortality in the elderly, RSV-bacteria co-infection had rarely ...
Ju-Chien Hsueh   +3 more
doaj   +1 more source

The respiratory microbiome is linked to the severity of RSV infections and the persistence of symptoms in children

open access: yesCell Reports Medicine
Summary: Respiratory syncytial virus (RSV) is the leading cause of infant respiratory infections and hospitalizations. To investigate the relationship between the respiratory microbiome and RSV infection, we sequence nasopharyngeal samples from a birth ...
Maartje Kristensen   +20 more
doaj   +1 more source

Isolation of respiratory syncytial virus from nasopharyngeal aspirates stored at 20ºC from one to fifteen months after collection

open access: yesMemorias do Instituto Oswaldo Cruz, 2006
Cell culture isolation is used for recovering respiratory syncytial virus (RSV) from respiratory specimens. As RSV is a thermolabile virus, specimens destined for inoculation into cell culture require special transport, handling, and storage.
IFS Nunes, FEA Moura
doaj   +1 more source

A Holistic Platform Approach for Developing Robust Pulmonary mRNA Delivery: Integrating Novel Phenolic Acid‐Derived Ionizable Lipids and Device Engineering

open access: yesAdvanced Functional Materials, EarlyView.
An integrated pulmonary mRNA delivery platform combining novel biodegradable syringic acid‐derived ionizable lipids, design‐of‐experiments formulation optimization, and vibrating‐mesh nebulizer engineering enabled stable aerosolization and efficient lung delivery.
Neha Kaushal   +21 more
wiley   +1 more source

Home - About - Disclaimer - Privacy